Literature DB >> 16835704

Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.

Mario R D'Andrea1, Maria R Limiti, Mario Bari, Pamela Zambenedetti, Adriana Montagutti, Francesca Ricci, Giovanni L Pappagallo, Donata Sartori, Orazio Vinante, Pietro L Mingazzini.   

Abstract

This study investigated the changes, if any, in the level of expression of a well defined panel of cell proliferation, differentiation and apoptosis markers between the primary breast tumor and the corresponding synchronous lymph node metastasis from a population of patients with a comparable disease status, in terms of clinical features, and natural history.Ninety pure invasive ductal carcinomas with 10 or more axillary lymph nodes involved and without evidence of distant metastasis were included in this study. Primary tumor and corresponding metastatic lymph node tissue specimens were evaluated for the expression of Cyclin B1, MMP1 metalloproteinase, ICAM-1, RARbeta, Ki67, ER, PgR, p53, bcl-2 and c-erbB2 by immunohistochemistry using standard methods. The bivariate Pearson correlation analysis demonstrated a close relationship between primary and matching corresponding metastatic node. A high grade of correlation has been maintained even when staining results where categorized as positive/negative according to each one marker cut-off level of staining expression. We report the most extensive immunohistochemical analysis of biological determinants in a well defined population of patients with invasive ductal carcinomas and involvement of 10 or more axillary nodes and no distant metastasis. We found a close correlation between the primary tumor and corresponding metastatic node in terms of the expression of all 10 of the markers investigated in this study. The not complete concordance observed could be explained by the gene expression modulation by extrinsic factors and by the microenvironment in which the cancer cells reside.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835704     DOI: 10.1007/s10549-006-9300-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.

Authors:  André Filipe Vieira; Maria Rita Dionísio; Madalena Gomes; Jorge F Cameselle-Teijeiro; Manuela Lacerda; Isabel Amendoeira; Fernando Schmitt; Joana Paredes
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

2.  Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.

Authors:  Naoki Niikura; Jun Liu; Naoki Hayashi; Elizabeth A Mittendorf; Yun Gong; Shana L Palla; Yutaka Tokuda; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

3.  Collision metastasis of breast and thyroid carcinoma to a single cervical lymph node: report of a case.

Authors:  Hong Zeng; Chao Liu; Yun-jie Zeng; Lin Wang; Geng-biao Chen; Xi-ming Shen
Journal:  Surg Today       Date:  2012-04-07       Impact factor: 2.549

4.  Heterogeneity of Bcl-2 expression in metastatic breast carcinoma.

Authors:  Andrea Proctor Subhawong; Hind Nassar; Marc K Halushka; Peter B Illei; Russell Vang; Pedram Argani
Journal:  Mod Pathol       Date:  2010-05-21       Impact factor: 7.842

5.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

6.  Three Metachronous Cases of HER2-Positive Breast Cancer Accompanied with Thyroid Cancer.

Authors:  Qiqi Gao; Yulong Zheng; Bo Wang; Zihan Wu; Guoping Ren
Journal:  Breast Care (Basel)       Date:  2014-10       Impact factor: 2.860

7.  Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.

Authors:  Vassiliki Kotoula; Konstantine T Kalogeras; George Kouvatseas; Despoina Televantou; Ralf Kronenwett; Ralph M Wirtz; George Fountzilas
Journal:  Virchows Arch       Date:  2012-12-20       Impact factor: 4.064

Review 8.  Latest biopsy approach for suspected metastases in patients with breast cancer.

Authors:  Naoki Niikura; Bruno C Odisio; Yutaka Tokuda; Fraser W Symmans; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Nat Rev Clin Oncol       Date:  2013-10-22       Impact factor: 66.675

9.  A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer.

Authors:  Chiao-Yun Lin; Angel Chao; Tzu-Hao Wang; Swei Hsueh; Yun-Shien Lee; Tzu-I Wu; An-Shine Chao; Huei-Jean Huang; Hung-Hsueh Chou; Ting-Chang Chang; Chyong-Huey Lai
Journal:  J Mol Med (Berl)       Date:  2014-05-14       Impact factor: 4.599

10.  HER-2/Neu and Hormone Receptor Analysis in Breast Carcinomas and Their Association with Clinicopathologic Parameters.

Authors:  Reşit Doğan Köseoğlu; Fatma Markoç; Ahmet Müslehiddinoğlu; Ayşe Burcu İleri; Faik Alev Deresoy; İlker Etikan
Journal:  Eur J Breast Health       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.